News from guerbet A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages

Latest

14 Mar, 2017, 10:15 GMT Guerbet: Gadolinium-based Contrast Agents: update on PRAC recommendations

Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, takes note of the recommendations issued by...


27 Feb, 2017, 11:43 GMT Guerbet Will Present Its Innovative Solutions for Medical Imaging at ECR 2017

From March 1 to 5 in Vienna (Austria) Guerbet (FR0000032526 GBT), a global specialist in contrast products and solutions for medical imaging, has...


15 Nov, 2016, 07:00 GMT Guerbet, a New Global Leader En Route to the Future

In 90 years the Group has built a success story fueled by innovation and international growth Guerbet(FR0000032526 GBT), the global specialist in...


29 Oct, 2015, 10:32 GMT Guerbet Signs Agreement with Kyuan for Promotion & Distribution of Lipiodol® Ultra-Fluid in China

Guerbet (GBT) announced today the signing of an agreement with Beijing Kyuan Pharmaceutical Co., Ltd., one of the major pharmaceutical drugs...


07 Mar, 2014, 07:00 GMT FlowSens®: A New-generation Solution in CT Imaging

 Presented for the first time at the European Congress of Radiology (ECR, Vienna, 7-10 March 2014), this unique, innovative solution enables Guerbet ...


27 Mar, 2013, 18:00 GMT FDA Approves Dotarem® (gadoterate meglumine), First Macrocyclic and Ionic Gadolinium-based Contrast Agent in USA

Guerbet announced today that the US Food and Drug Administration (FDA) has approved Dotarem® (gadoterate meglumine), a gadolinium-based contrast...